期刊文献+

牛磺酸对链脲佐菌素诱导的糖尿病幼鼠氧化应激系统及早期血管内皮损伤的干预性研究 被引量:3

Effects of early intervention with taurine on oxLDL/LOX-1 system and vascular endothelial dysfunction in young streptozotocin-induced diabetic rats
原文传递
导出
摘要 目的观察牛磺酸对糖尿病幼鼠氧化应激系统(oxLDL/LOX-1)的影响及早期血管内皮损伤的干预作用,探讨其可能的分子机制。方法6周龄Wistar雄性大鼠30只随机取出8只作为正常对照组,其余给予链脲佐菌素(60mg/kg)一次性腹腔注射诱导1型糖尿病模型,造模成功后随机各取8只分为糖尿病未干预组和糖尿病牛磺酸干预组(每日饮水中加入1%牛磺酸)。干预4周后处死大鼠,检测大鼠外周血血糖、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)、氧化低密度脂蛋白(oxLDL)及可溶性细胞间黏附分子1(sICAM-1);采用免疫组织化学法、免疫印迹和逆转录一聚合酶链反应法,分别检测腹主动脉壁血凝素样氧化低密度脂蛋白受体1(LOX-1)和细胞间黏附分子1(ICAM-1)蛋白及基因表达水平。结果糖尿病未干预组外周血TG、TC、LDL及oxLDL、sICAM-1水平均高于正常对照组(P均〈0.01);腹主动脉壁LOX—1和ICAM-1的蛋白及基因表达水平亦明显高于正常对照组(P均〈0.01);糖尿病牛磺酸干预组较糖尿病未干预组外周血TG(0.64±0.12与0.97±0.18)、TC(0.82±0.18与1.01±0.23)、oxLDL(3.1±0.6与4.2±0.6)、sICAM-1(108.3±18.0与130.7±17.4)水平和腹主动脉壁LOX.1、ICAM-1蛋白(1.02±0.19与2.60±0.33,1.21±0.22与2.98±0.31)及基因表达水平(0.45±0.09与0.96±0.15,0.50±0.07与0.87±0.16)均明显下降(P均〈0.05)。LOX-1的蛋白表达水平与血清oxLDL(r=0.922,P=0.001)、sICAM-1(r=0.753,P=0.031)以及腹主动脉ICAM-1(r=0.849,P=0.008)的蛋白表达水平均呈正相关。结论糖尿病幼鼠存在血管内皮细胞功能损伤,牛磺酸早期干预对糖尿病幼鼠血管内皮具有保护作用。 Objective As an endogenous antioxidant, taurine could retard the development of diabetic cardiovascular complications. Whereas, whether TAU has a protective effect on diabetic vascular endothelium in young patients is still unclear. This study aimed to investigate the protective effect of taurine on early vascular endothelial dysfunction and its possible mechanism by detecting the changes of oxLDL/ LOX-1 system in young STZ-induced diabetic rats. Doing so, the authors expect to find an effective approach in clinical practice to the prevention and treatment of diabetic vascular complication. Method Six-week-old rats were divided randomly into normal control ( CN group, n = 8 ), diabetes mellitus group ( DM group, n = 8) and taurine supplement group (DM + TAU group, n = 8) . Diabetes was induced in the rats by intraperitoneal injection of streptozotocin ( STZ, 60 mg/kg) and after the onset of diabetes, the rats in DM + TAU group were given free access to drinking water containing 1% taurine. At the end of 4 weeks, blood glucose, serum total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL) and high-density lipoprotein (HDL), oxidized low density lipoprotein (oxLDL) and sICAM-1 levels were determined, meanwhile LOX-1 and ICAM-1 expression on abdominal aortas were examined by immunostaining, Western blotting and reverse transcription PCR, respectively. The results were quantified by densitometry. Result Compared to normal control,in STZ-induced diabetic rats, the levels of serum TC, TG, LDL, oxLDL and sICAM-1 were all increased ( P 〈 0. 01 for all), meanwhile LOX-1 and ICAM-1 expression ( protein and mRNA) in the endothelium layers of abdominal aortas were also markedly enhanced (P 〈 0. 01 for all); while in taurine supplemented rats, the levels of serum TG (0. 64 ±0. 12 vs. 0. 97 ±0. 18) , TC (0. 82 ± 0.18vs. 1.01±0.23), oxLDL (3.1±0.6 vs. 4.2±0.6), sICAM-1 (108.3±18.0 vs. 130.7 ±17.4), expression of LOX-1 and ICAM-1 protein (1.02±0. 19 vs. 2. 60 ±0. 33, 1.21 ±0. 22 vs. 2. 98±0. 31) as well as mRNA (0.45 ±0. 09 vs. 0. 96 ±0. 15, 0. 50 ±0. 07 vs.0. 87 ±0. 16) were all markedly lower than those of untreated diabetic rats ( P 〈 0. 05 for all ). Also, the level of LOX-1 protein expression was positively correlated with levels of serum oxLDL ( r = 0. 922, P = 0. 001 ) , sICAM-1 ( r = 0. 753, P = 0. 031) and ICAM-1 expression on abdominal aorta (r = 0. 849, P = 0. 008). Conclusion Vascular endothelial dysfunction was present in early stage of young diabetic rats and taurine supplement could protect against this early endothelial dysfunction by its antioxidation to inhibit the role of oxLDL/LOX-1 system in young rats with diabetes mellitus.
出处 《中华儿科杂志》 CAS CSCD 北大核心 2009年第3期194-199,共6页 Chinese Journal of Pediatrics
基金 教育部博士点基金(20050422050) 山东省优秀中青年科学家科研基金(200685003065)
关键词 糖尿病 1型 牛磺酸 脂蛋白类LDL 受体 LDL Diabetes mellitus, type 1 Taurine Lipoprotein, LDL Receptor, LDL
  • 相关文献

参考文献15

  • 1于永慧,陈瑶,汪翼.儿童期动脉粥样硬化的防治研究[J].中华儿科杂志,2005,43(7):547-550. 被引量:2
  • 2Mehta JL, Li D. Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor. J Am Coll Cardiol, 2002,39 : 1429-1435.
  • 3Li F, Obrosova IG, Abatan O, et al. Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats. Am J Physiol Endoerinol Metab, 2005, 288 : E29-36.
  • 4Li C, Cao L, Zeng Q, et al. Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin Ⅱ Type 2 receptor expression. Cardiovasc Drugs Ther,2005,19 : 105-112.
  • 5Jarcisalo MJ, Lehtimaiki T, Raitakari OT. Determinants of arterial nitrate-mediated dilatation in children : role of oxidized low-density lipoprotein, endothelial function, and carotid intima-media thickness. Circulation ,2004,109:2885-2889.
  • 6Xu X, Gao X, Potter BJ, et al. Anti-LOX-1 rescues endothelial function in coronary arterioles in atherosclerotic ApoE knockout mice. Arterioscler Thromb Vasc Biol,2007,27 : 871-877.
  • 7Matsumoto K, Sera Y, Ueki Y, et al. Comparision of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy. Diabet Med ,2002,19:822- 826.
  • 8Li D, Liu L, Chen H, et al. LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial ceils. Circulation, 2003,107 : 612-617.
  • 9Chen M, Nagase M, Fujita T, et al. Diabetes enhances lectin-like oxidized LDL receptor-1 (LOX-1) expression in the vascular endothelium: possible role of LOX-I ligand and AGE. Biochem Biophys Res Commun,2001,287:962-968.
  • 10De Castro SH, Castro-Faria-Neto HC, Gomes MB. Association of postprandial hyperglycemia with in vitro LDL oxidative in non- smoking patients with type 1 diabetes-a cross-sectional study. Rev Diabet Stud ,2005,2 : 157-164.

二级参考文献30

  • 1Imakita M, Yutani C, Strong JP, et al. Second nation-wide study of atherosclerosis in infants, children and young adults in Japan. Atherosclerosis, 2001, 155: 487-497.
  • 2McGill HC Jr, McMahan CA, Herderick EE, et al. Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr, 2000, 72: 1307-1315.
  • 3Li S, Chen W, Srinivasan SR, et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA, 2003, 290: 2271-2276.
  • 4Glowinska B, Urban M, Koput A, et al. New atherosclerosis risk factors in obese, hypertensive and diabetic children and adolescents. Atherosclerosis, 2003, 167: 275-286.
  • 5Ten S, Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab, 2004, 89: 2526-2539.
  • 6Napoli C, Glass CK, Witztum JL, et al. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet, 1999, 354: 1234-1241.
  • 7Naoumova RP, Neuwirth C, Lee P, et al. Autosomal recessive hypercholesterolaemia: long-term follow up and response to treatment. Atherosclerosis, 2004, 174:165-172.
  • 8Francova H, Trbusek M, Zapletalova P, et al. New promoter mutations in the low-density lipoprotein receptor gene which induce familial hypercholesterolaemia phenotype: molecular and functional analysis. J Inherit Metab Dis, 2004, 27: 523-528.
  • 9Nomiyama T, Tanaka Y, Piao L, et al. Accumulation of somatic mutation in mitochondrial DNA and atherosclerosis in diabetic patients. Ann N Y Acad Sci, 2004, 1011: 193-204.
  • 10Romaldini CC, Issler H, Cardoso AL, et al. Risk factors for atherosclerosis in children and adolescents with family history of premature coronary artery disease. J Pediatr (Rio J), 2004, 80: 135-140.

共引文献1

同被引文献47

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部